Hypertension management in chronic kidney disease:adherence to intensive blood pressure control and long-term time in target rangeZHOU Shuwen, CAI Guangyan1323-1327
Precision medicine for IgA nephropathy:frontiers in epidemiology and pathogenesisZHOU Ruijia, LIU Hong1328-1335
Rho kinase signaling pathway mediates high uric acid-induced oxidative damage and apoptosis of renal tubular cells by regulating mitochondrial dynamin and biosynthesis related genesLI Jiachang, MA Yuhan, WEI Jiali1336-1341
Exploration on mechanism of action of nalfurafine in treatment of chronic kidney disease-associated pruritus based on network pharmacology and molecular docking techniquesLI Jing, SHI Jingxuan, WANG Xu, ZHANG Zheng, ZHUO Li, LI Wenge1342-1348
Artificial intelligence empowers kidney disease research:mechanism exploration and treatment optimizationMENG Lingzhang, YANG Mingyue, XIONG Lijia, WEI Suosu, HUANG Xiaoyuan, LIANG Huaqian, MAO Xiuli, ZHANG Xiamin, LIN Wenxian, YE Kun1349-1353
Analysis on the efficacy and safety of rituximab in treatment of refractory primary focal segmental glomerulosclerosis in adultsGUAN Lisi, YE Kun, WEI Qiaoyu, DENG Meiqiu, HUANG Shaorong1354-1359
Study on the role and molecular mechanism of HMGN1 in acute kidney injury based on the NLRP3 inflammatory pathwayLUO Yuhan, SHAO Xingqin, ZHANG Lang, XIE Ying, YUAN Jing, ZHA Yan, LIN Xin1360-1365
Study on correlations of serum miR-27b-3p and miR-142-5p levels with disease progression of clear cell renal cell carcinoma and poor prognosis after retroperitoneal laparoscopic partial nephrectomyZHANG Yuan, YAN Yuying, BIAN Yajin, WANG Xueying1366-1371
Effects of HSA,IVIG and ATG infusions on blood transfusion compatibility testingTAI Shengfei, CHENG Tingting, XU Binglin, FU Lihui, MA Chunya, YU Yang1372-1377
Analysis on associations of IL-17A,ICAM-1 and MUC5AC levels in bronchoalveolar lavage fluid and serum with MPP complicating AMP and clinical prognosis in pediatric patientsLI Fang, ZOU Deng, LEI Chaolan, PENG Xinxin, LEI Yuan1378-1384